Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Chest Computed Tomography (CT) imaging has become an indispensable tool for staging and managing COVID-19. The current evaluation of COVID-19-associated anomalies relies mainly on visual scoring, a subjective and time-consuming process for clinicians. Therefore, there is a critical need for automated methods to quantify CT imaging anomalies for COVID-19, providing vital assistance to healthcare professionals.